CRISPR Therapeutics

CRISPR Therapeutics

Zug, Switzerland
Is it you?
Investor info
Type
Corporate Venture Capital
Stage focus
  • Early stage VC
Geography focus
United States
Industry focus
Description
CRISPR Therapeutics is a Zug-based biotechnology company and strategic corporate investor focused on gene-based medicines and CRISPR/Cas9 editing. It is relevant for early-stage U.S. biotechnology, life sciences and pharmaceutical startups where strategic alignment with gene-editing therapeutics is important.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
X Feed
See other investors focused on
Biotechnology
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.